SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-032725
Filing Date
2022-02-09
Accepted
2022-02-09 16:25:53
Documents
2
Group Members
JASON HOWERTON

Document Format Files

Seq Description Document Type Size
1 SC 13G d311735dsc13g.htm SC 13G 57231
2 EX-99.A d311735dex99a.htm EX-99.A 3279
  Complete submission text file 0001193125-22-032725.txt   62125
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Subject) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92462 | Film No.: 22607568
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011
Business Address C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011 858-293-4900
Star Irrevocable Trust #1 dated April 22, 2019 (Filed by) CIK: 0001849576 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G